the very widely used antibiotics, useful in the treatment of a variety of infectious deseases2~4). Several methods for the determination of these antiobitics in plasma and tissue, including microbial test systems5*, radioimmunoassay6) and liquid chromatography7'8), have been described. Molecular imprinting9) of organic compounds is increasingly recognised as a facile technique for the preparation of polymeric materials containing recognition sites of predetermined specificity.
The resulting polymers retain a memoryfor the print molecule and can be used in the HPLCmodefor separation of structurally similar substances, and (in case of single enantiomer imprinting) resolution of the enantiomers of the print species10). Polymerisation of monomers, which are selected for their ability to engage in non-covalent interactions with specific functionality of the print molecule, constitutes the key step. Subsequent removal of the print molecule exposes sites within the polymer matrix whose chemical and steric topography is defined by the print molecule present during its preparation. These memory sites enable the polymer to later rebind the print molecule, in many instances with binding affinities and specificities approaching those demonstrated by antigen-antibody systemsll;'140. This paper describes the molecular imprinting of some macrolide antibiotics and the use of the resultant polymers as stationary phases with predetermined selectivity in HPLC.
Materials and Methods
Polymer Preparation Polymers were prepared according to a methodde- of ethylene glycol dimethacrylate and 344mg of methacrylic acid were weighed into 20 ml borosilicate test tubes and dissolved in 6 ml of dried methylene chloride.
A blank polymer was produced by omitting the print molecule. The mixtures were cooled on ice, sonicated and sparged with nitrogen for 5 minutes. Fifty mg of azobis-(isobutyronitrile) (initiator) was added and the ampoules were placed under a UV-source (366nm) for 16 hours at 4°C. The bulk polymers were ground in a mechanical mortar (Retsch, Haan, Germany) and wet-sieved through a 25/mi sieve (Retsch, Haan, Germany). Fines were removedby repeated sedimentation from acetonitrile and the polymer particles were finally dried under vacuum.
HPLC Analysis
Polymer particles were packed into stainless steel columns (200 x 4.6mm) as described in10). In order to extract the imprint species, the columns were washed on line with methanol -acetic acid (9 : 1; v/v; 1 liter) and then with the eluent. Twenty jj\ of 0.1 mMsamples (dissolved in the eluent) were analysed isocratically at a flow rate of 1ml/minute. The eluents were: 0.5% acetic acid in chloroform (erythromycin polymer); 1%acetic acid in chloroform (oleandomycin polymer); 1 % acetic acid in methylene chloride (tylosin polymer). Acetone was used as a void marker. Retention factors were calculated using k/=(VR-V0)/V0, where VRis the retention volume of the compound and Vo is the void volume of the system. Separation factor is a^k^/k^, where kj is the retention factor recorded for the print species and k'2 is that for the second compound. Plate numbers (N), which were around 5000m" 1 for all columns, was calculated using standard chromatographic theory1 2).
Results and Discussion
Molecular imprinting of macrolide antibiotic structures were done in methacrylic acid-ethylene glycol dimethacrylate copolymers. The resultant molecularly imprinted polymers (MIPs) were packed into HPLCcolumns and their specific separation abilities were JAN. 1997 analysed, as has been described in previous studies of imprinted polymers10). For each compound the retention factor, k', is related to the relative binding affinity of the compoundto the imprinted polymer. The extent of retention of a given compoundon a column is, however, composed of two factors: the specific binding to the imprinted sites and non-specific retention due to interaction with the surface of the polymer. Non-specific interactions could be reduced to a minimumby addition of small amounts of acetic acid to the eluent10).
All polymers showed strongest affinity for the compound that was present during its preparation (Table  1) . In all instances, other macrolides were less well recognised, i.e. other macrolides eluted earlier than the print species. On the column packed with oleandomycin MIP, the print molecule was completely separated from mixtures with erythromycin and tylosin, with separation factors (a) of 6.8 and 5.7, respectively. The same is true for erythromycin and tylosin MIPs. On the column packed with erythromycin MIP, erythromycin is more strongly retained than oleandomycin and tylosin (a = 5.0 and 2.4, respectively). On the tylosin column, a much higher retention factor was recorded for tylosin than for oleandomycin and erythromycin; in this instance a=.
8.2 and 2.9 were obtained. A non-imprinted reference polymer, made under otherwise identical conditions but by omitting the print molecule, was not able to retain any of the compoundstested. With the same mobile phase as used for the imprinted columns, all compounds eluted with the void (k'=0.0). In all instances, the increased retention of the imprint species relative to other compounds is high, indicating a high specificity of each MIP. In this context, unrelated compounds, such as cyclosporin and rifampicin, eluted with the void (k' = 0.0) or was slightly retained (k'= 1.0) on the oleandomycin polymer (Table 1 ), which further demonstrate the specificity of the imprints. The slight retention of rifampicin may be explained by some structural similarities to the ansa chain of rifampicin to the macrolide ring of the imprint species. The very high separations obtained make these polymers useful in The eluent was methylene chloride containing 1 % acetic acid at a flow rate of 1 ml/minute. Detection was at 290 nm. Note the strong adsorption of tylosin at this wavelength.
chromatographic separations of the imprint species from a mixture of antibiotics and related compounds (Fig. 2) .
The data presented here demonstrate the ability of molecular imprinting to provide an easy access to stationary phases with high specificity of the desired macrolide structure.
At least in one instance, the polymer was able to detect subtle structural differences.
On the erythromycin column, 2'-esters of erythromycin eluted muchearlier than erythromycin itself did. The parent compoundwas separated from its ethyl succinate, stearate and estolate ester derivatives with separation factors of 7.6, 5.2 and 3.4, respectively (Table 1 ). In contrast, the bulky molecules tylosin and spiramycin gave similar retention values on the tylosin column, with spiramycin eluting only slightly prior to tylosin (Table 1) . A possible explanation is their identical disaccharide unit combined with the many structural similarities in the macrocyclic ring.
In conclusion, we have demonstrated the molecular As part of our program in this area, we have recently designed, synthesized and studied 4-0-alkyl-L-cladinose analogues, compounds (1~5), including 9-dehydro-3"-0-methyl-4"-0-(3-methylbutyl)-3-0-propionylleucomycin V3), compound 3 (Scheme 1). In this communication, we wish to report the preparation of the potentially more useful C-9 hydroxyl analogues, compounds 6~10.
The reported compound 8 exhibited dramatically improved pharmacokinetics in mice.
As we reported in our previous paper3), one of the 4-0-alkyl-L-cladinose analogues, 3, showed better pharmacokinetics in mice comparedto midecamycinA3 ( Fig. 1 ) having 4-O-acylated sugar moiety. Pharmacokinetic comparison between midecamycin A1 and A3 in mice in vivo4) (Fig. 1) led us to reduce a carbonyl group at the C-9 position to generate an a-hydroxyl group stereoselectively. As a result of this modification, improvementin both serum concentration and urinary excretion in vivo was achieved. Some methods for reducing the C-9 carbonyl of sixteen-membered macrolides to the alcohol through synthetic approaches5~7) and biochemical approaches8~11} have been reported. After careful consideration of these methodologies, we chose the biotransformation9'10) of these compounds because of the exclusive stereoselectivity and ease of procedure.
Bioconversion of a C-9 carbonyl to a corresponding a-hydroxyl group was successfully completed in spite of the presence of an unnatural sugar (4-0-alkyl-Lcladinose). In general, the medium1" was pipetted in 80 ml T A medium comprising 2.0% of glucose, 1.0% ofpolypeptone, 0.05% ofdipotassium hydrogenphosphate, 0.05% of magnesium sulfate heptahydrate and 0.3% of sodium chloride was adjusted to pH7.0 and sterilized prior to the use. Next, 1.2 ml of a methanol solution containing 20 mg of preparative TLC[developing system : chloroform/meththe carbonyl compound was added to each flask in 0.4ml anol (10 : 1)]. Thus, 9~12mg (45~60%) of the desired portions and the incubation was continued at 28°C for a-hydroxyl compoundswere obtained with trace of a 17 hours while shaking. After the completion of the starting material. For example, evidence of the desired incubation, the culture was centrifuged at 3000 rpm for a-hydroxyl stereochemistry for compound 8 was dem-10 minutes. Thus 180ml of a transparent culture onstrated by XHNMRexperiments (5 4.07 (1H, dd, supernatant was obtained while the solid matters in-/8 9=4.0Hz, J9 10= 10.0Hz, 9-H))6). eluding the cells were removed. To the solid matters The antibacterial activities in vitro of novel 4-O-alkylwas added 120ml of water and the mixture was stirred L-cladinosyl derivatives (6~10), compared with correfollowed by centrifugation. The washing liquor thus sponding midecamycin A1? are shown in Table lft. obtained was combined with the above-mentioned Although compounds 7 and 8 displayed similar in vitro transparent culture supernatant. After adjusting the activities to midecamycin Al5 their activities against mixture to pH 9 with a I n aqueous solution of sodium Streptococcus pneumoniae were clearly enhanced comhydroxide, the conversion product was extracted with pared with midecamycin A1. The activity of 8 against 300ml portions of ethyl acetate twice. The ethyl acetate Mycoplasmapneumoniae was also quite high. As exlayer was dried over anhydrous sodium sulfate and then pected, stereoselective reduction at the C-9 position of filtered. The filtrate was concentrated under reduced 9-keto derivatives did not reduce their original antipressure and the residue thus obtained was purified by bacterial activities. These compounds (7~9) also exhibited good metabolic stability in rat plasma in vitro. After 24 hours of incubationtf, 71, 85, and 79% of initial activity (t=0) was observed against Micrococcus luteus for compound 7, 8, and 9, respectively, while only 2% activity remained for mideCamycin Ax. Thus, these 4-O-alkyl-L-cladinosyl analogues proved to be more stable than midecamycin Ax in vitro. Improved stability is best explained by inability of neutral sugars to be metabolized by esterase1 2). Compound(8), which was the best compoundin terms of potency and stability, was finally examined in vivo.
Serumconcentrations of antibiotics in mice after 200 mg/kg oral administration1"n are shown in Fig. 2 . Serum concentration of 8 was dramatically higher and longer lasting than midecamycin A1 and its AUCwas also greater than that of midecamycin At. The maximum concentration of 8 in serum was comparable to that of mA test compound was mixed with a 0.2% aqueous solution of CMCto give a concentration of 4.0mg/ml and a 1.0ml portion of the resulting emulsion was orally administered to 4 weeks old male Jcl : ICR mice. Blood was collected from the armpits of the mice 0.5, 1, 2 ,4 and 6 hours after the administration of the test compound (n=2). The collected blood was allowed to stand at 0°C for 2 hours and centrifuged at 3000rpm for 20 minutes to obtain serum. To the serum was added an equivalent volume of 50%CH3CN-0.05Mphosphate buffer (pH 7.0). The resulting mixture served as a serum sample. The concentration of the test compound in the serum sample was measured by a bioassay method using M. luteus ATCC9341. 
